93%(29)27 out of 29 people found this document helpful
This preview shows page 5 - 7 out of 8 pages.
5. Develop a teaching plan for a patient using zolpidem (Ambien) for sleep. Include nonpharmacologic measures in the plan. Zolpidem •Indications: Zolpidem tartrate tablets, USP are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets, USP have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies (14)]. •Dosage Forms and Strengths: Zolpidem tartrate is available in 5 mg and 10 mg strength tablets for oral administration. Tablets are not scored. Zolpidem tartrate tablets 5 mg are white to off-white, circular, biconvex, film-coated tablets, debossed with “E” on one side and “78” on the other side. Zolpidem tartrate tablets 10 mg are white to off-white, oval shaped, biconvex, film-coated tablets, debossed with “E” on one side and “79” on the other side. •Contraindications: Zolpidem tartrate tablets are contraindicated in patients with known hypersensitivity to Zolpidem. Observed reactions include anaphylaxis and angioedema •Drug Interactions: Co-administration of Zolpidem with other CNS depressants increases the risk of CNS depression. Zolpidem tartrate was evaluated in healthy volunteers in single-dose interaction studies for several CNS drugs. Group Assignments 1. Construct a table listing the therapeutic actions, pharmacokinetics, contraindications, most common adverse reactions, and important drug–drug interactions associated with each class of anxiolytic or hypnotic agent: benzodiazepines and barbiturates. Are the benzodiazepines or the barbiturates more desirable?